Cocktail of prostate drugs could shrink tumours, 총리는 새 여론조사에서 노동당이 10점 만점으로 앞서면서 채찍 마크 스펜서를 축출하고 제이콥 리스-모그를 승진시킬 것으로 예상되는 미니 개편을 앞두고 내각을 소집했다.

New prostate drug hope: Cocktail of medications could shrink tumours and cuts deaths by a QUARTER, 총리는 새 여론조사에서 노동당이 10점 만점으로 앞서면서 채찍 마크 스펜서를 축출하고 제이콥 리스-모그를 승진시킬 것으로 예상되는 미니 개편을 앞두고 내각을 소집했다.

  • A new combination of prostate cancer drugs can cut deaths and shrink tumours
  • Patients given two different pills were three times more likely to have remission
  • Cancer research and NHS doctors have described their findings as ‘promising
  • Thousands of men could benefit from a new combination of prostate cancer drugs which cut deaths and shrink tumours.

    Patients given two different pills were three times more likely to experience complete remission than those given only one, a trial found.

    They were also 23 per cent less likely to die or see their tumour grow or spread.

    Doctors at the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust described their findings as ‘promising’.

    Thousands of men could benefit from a new combination of prostate cancer drugs which cut deaths and shrink tumours (스톡 이미지)

    Thousands of men could benefit from a new combination of prostate cancer drugs which cut deaths and shrink tumours (스톡 이미지)

    And they believe it could improve treatment for more than 10,000 men a year who have advanced prostate cancer with a faulty PTEN gene.

    The PTEN gene usually works to suppress tumour growth.

    하나, half of advanced prostate cancers do not have it, meaning they tend to be more aggressive and have a worse outcome.

    The research, published in The Lancet, 관련된 1,101 men in 26 국가.

    All patients had advanced prostate cancer and had received no previous treatment, and half had tumours without a fully-functioning PTEN gene.

    Some participants were given both the existing drug abiraterone, which is standard treatment for many men, and the experimental drug ipatasertib.

    Patients given two different pills were three times more likely to experience complete remission than those given only one, a trial found (스톡 이미지)

    Patients given two different pills were three times more likely to experience complete remission than those given only one, a trial found (스톡 이미지)

    Others received just abiraterone and a placebo.

    Of the patients without the gene, 61 per cent saw their tumour get smaller when they took both drugs. 뿐 39 per cent saw the same result when they took the one.

    하나, two drugs proved no better than one when tumours had a fully-functioning PTEN gene.

    Professor Paul Workman, chief executive of the ICR, praised the findings, saying the combination could ‘extend the time before men’s prostate cancer worsensso that ‘they can spend as much time as possible with their loved ones’.

    The Daily Mail has long campaigned for better awareness, treatment and diagnosis of the disease.